| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Hetastarch adverse reaction |
Causative agent (attribute) |
True |
Hetastarch (substance) |
Inferred relationship |
Some |
1 |
| Hetastarch allergy |
Causative agent (attribute) |
False |
Hetastarch (substance) |
Inferred relationship |
Some |
|
| hetastarch 6% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hetastarch (substance) |
Inferred relationship |
Some |
|
| Hetastarch 6g liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hetastarch (substance) |
Inferred relationship |
Some |
|
| Hetastarch 6% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hetastarch (substance) |
Inferred relationship |
Some |
|
| Product containing hetastarch (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hetastarch (substance) |
Inferred relationship |
Some |
1 |
| héta-amidon à 10 %, flacon d'une solution pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hetastarch (substance) |
Inferred relationship |
Some |
|
| Sodium chloride 7.2%/hetastarch 6% injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hetastarch (substance) |
Inferred relationship |
Some |
|
| Product containing hetastarch and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hetastarch (substance) |
Inferred relationship |
Some |
1 |
| Hetastarch 6%/sodium chloride 0.9% injection solution 500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hetastarch (substance) |
Inferred relationship |
Some |
|
| Non-allergic hypersensitivity to hetastarch (finding) |
Causative agent (attribute) |
False |
Hetastarch (substance) |
Inferred relationship |
Some |
|
| Non-allergic hypersensitivity to hetastarch (finding) |
Causative agent (attribute) |
False |
Hetastarch (substance) |
Inferred relationship |
Some |
2 |
| Non-allergic hypersensitivity to hetastarch (finding) |
Causative agent (attribute) |
True |
Hetastarch (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hetastarch (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hetastarch (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hetastarch and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hetastarch (substance) |
Inferred relationship |
Some |
1 |
| Hetastarch 60 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hetastarch (substance) |
Inferred relationship |
Some |
1 |
| Hetastarch 60 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hetastarch (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hetastarch in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hetastarch (substance) |
Inferred relationship |
Some |
1 |
| Product containing hetastarch in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hetastarch (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]